Renaissance Technologies’s Exagen XGN Stock Holding History

Renaissance Technologies’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$184K	Sell	39,600 -163,672	-81%	-$616K	﹤0.01%	2896
2026 Q1	$610K	Buy	203,272 +65,272	+47%	+$252K	﹤0.01%	2517
2025 Q4	$839K	Buy	+138,000	New	+$1.26M	﹤0.01%	2366
2025 Q3	–	Sell	-21,000	Closed	-$147K	–	3997
2025 Q2	$147K	Sell	21,000 -115,800	-85%	-$704K	﹤0.01%	3232
2025 Q1	$491K	Sell	136,800 -18,736	-12%	-$70.7K	﹤0.01%	2754
2024 Q4	$638K	Sell	155,536 -20,064	-11%	-$72.3K	﹤0.01%	2733
2024 Q3	$543K	Buy	175,600 +81,366	+86%	+$211K	﹤0.01%	2757
2024 Q2	$172K	Buy	94,234 +45,476	+93%	+$77K	﹤0.01%	3075
2024 Q1	$78K	Buy	48,758 +3,270	+7%	+$6.35K	﹤0.01%	3412
2023 Q4	$91K	Buy	+45,488	New	+$78.7K	﹤0.01%	3328

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Renaissance Technologies's XGN Position: Q2 2026 in Review

Renaissance Technologies reduced its Exagen (XGN) stake by 81% in Q2 2026, selling an estimated $616K and leaving 39,600 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

Renaissance Technologies first reported a position in XGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $839K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

Renaissance Technologies held 39,600 shares of Exagen worth $184K as of Q2 2026.
Renaissance Technologies sold 163,672 Exagen shares in Q2 2026, an estimated $616K.
Exagen made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2896 holding.
Renaissance Technologies first reported a position in Exagen in Q4 2023 and has held it in 10 quarters since.
Renaissance Technologies's Exagen position peaked at $839K in Q4 2025.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.